1. Treatment of Nausea and Emesis During Cancer Chemotherapy
Sussanne Börjeson, RN, PhD, Timo J Hursti, DrMedSc, Carol Tishelman, RN, DrMedSc, Curt Peterson, MD, PhD, Gunnar Steineck, MD, PhD 
Journal of Pain and Symptom Management 
Volume 24, Issue 3, Pages (September 2002)
DOI: /S (02)

2. Figure 1
a. Proportions (%) of patients in each group free from acute nausea during cycles 1–4. b. Proportions (%) of patients in each group free from delayed nausea during cycles 1–4.
Journal of Pain and Symptom Management  , DOI: ( /S (02) )

3. Figure 1
a. Proportions (%) of patients in each group free from acute nausea during cycles 1–4. b. Proportions (%) of patients in each group free from delayed nausea during cycles 1–4.
Journal of Pain and Symptom Management  , DOI: ( /S (02) )

4. Figure 2
Mean change from baseline VAS rating of well-being to the ratings in cycles 1–4. A positive change means improved ratings of well-being compared to the baseline assessment.
Journal of Pain and Symptom Management  , DOI: ( /S (02) )